Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy

Vasu Tumati, Sanjeev Mathur, Kwang Song, Jer Tsong Hsieh, Dawen Zhao, Masaya Takahashi, Timothy Dobin, Leah Gandee, Timothy D. Solberg, Amyn A. Habib, Debabrata Saha

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The purpose of this study was to develop an aggressive locally advanced orthotopic prostate cancer model for assessing high-dose image-guided radiation therapy combined with biological agents. For this study, we used a modified human prostate cancer (PCa) cell line, PC3, in which we knocked down a tumor suppressor protein, DAB2IP (PC3 KD). These prostate cancer cells were implanted into the prostate of nude or Copenhagen rats using either open surgical implantation or a minimally invasive procedure under ultrasound guidance. We report that: i) these DAB2IP-deficient PCa cells form a single focus of locally advanced aggressive tumors in both nude and Copenhagen rats; ii) the resulting tumors are highly aggressive and are poorly controlled after treatment with radiation alone; iii) ultrasound-guided tumor cell implantation can be used successfully for tumor development in the rat prostate; iv) precise measurement of the tumor volume and the treatment planning for radiation therapy can be obtained from ultrasound and MRI, respectively; and v) the use of a fiducial marker for enhanced radiotherapy localization in the rat orthotopic tumor. This model recapitulates radiation-resistant prostate cancers which can be used to demonstrate and quantify therapeutic response to combined modality treatments.

Original languageEnglish (US)
Pages (from-to)1613-1619
Number of pages7
JournalInternational Journal of Oncology
Volume42
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Combined Modality Therapy
Prostate
Prostatic Neoplasms
Neoplasms
Radiotherapy
Fiducial Markers
Image-Guided Radiotherapy
Radiation
Nude Rats
Tumor Suppressor Proteins
Biological Factors
Therapeutics
Tumor Burden
Cell Line

Keywords

  • Animal MRI
  • Prostate cancer
  • Radioresistance
  • Ultra-sound and image-guided radiation therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy. / Tumati, Vasu; Mathur, Sanjeev; Song, Kwang; Hsieh, Jer Tsong; Zhao, Dawen; Takahashi, Masaya; Dobin, Timothy; Gandee, Leah; Solberg, Timothy D.; Habib, Amyn A.; Saha, Debabrata.

In: International Journal of Oncology, Vol. 42, No. 5, 05.2013, p. 1613-1619.

Research output: Contribution to journalArticle

Tumati, Vasu ; Mathur, Sanjeev ; Song, Kwang ; Hsieh, Jer Tsong ; Zhao, Dawen ; Takahashi, Masaya ; Dobin, Timothy ; Gandee, Leah ; Solberg, Timothy D. ; Habib, Amyn A. ; Saha, Debabrata. / Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy. In: International Journal of Oncology. 2013 ; Vol. 42, No. 5. pp. 1613-1619.
@article{0a8f93537f974c368f3a0d0902ac38c5,
title = "Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy",
abstract = "The purpose of this study was to develop an aggressive locally advanced orthotopic prostate cancer model for assessing high-dose image-guided radiation therapy combined with biological agents. For this study, we used a modified human prostate cancer (PCa) cell line, PC3, in which we knocked down a tumor suppressor protein, DAB2IP (PC3 KD). These prostate cancer cells were implanted into the prostate of nude or Copenhagen rats using either open surgical implantation or a minimally invasive procedure under ultrasound guidance. We report that: i) these DAB2IP-deficient PCa cells form a single focus of locally advanced aggressive tumors in both nude and Copenhagen rats; ii) the resulting tumors are highly aggressive and are poorly controlled after treatment with radiation alone; iii) ultrasound-guided tumor cell implantation can be used successfully for tumor development in the rat prostate; iv) precise measurement of the tumor volume and the treatment planning for radiation therapy can be obtained from ultrasound and MRI, respectively; and v) the use of a fiducial marker for enhanced radiotherapy localization in the rat orthotopic tumor. This model recapitulates radiation-resistant prostate cancers which can be used to demonstrate and quantify therapeutic response to combined modality treatments.",
keywords = "Animal MRI, Prostate cancer, Radioresistance, Ultra-sound and image-guided radiation therapy",
author = "Vasu Tumati and Sanjeev Mathur and Kwang Song and Hsieh, {Jer Tsong} and Dawen Zhao and Masaya Takahashi and Timothy Dobin and Leah Gandee and Solberg, {Timothy D.} and Habib, {Amyn A.} and Debabrata Saha",
year = "2013",
month = "5",
doi = "10.3892/ijo.2013.1858",
language = "English (US)",
volume = "42",
pages = "1613--1619",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy

AU - Tumati, Vasu

AU - Mathur, Sanjeev

AU - Song, Kwang

AU - Hsieh, Jer Tsong

AU - Zhao, Dawen

AU - Takahashi, Masaya

AU - Dobin, Timothy

AU - Gandee, Leah

AU - Solberg, Timothy D.

AU - Habib, Amyn A.

AU - Saha, Debabrata

PY - 2013/5

Y1 - 2013/5

N2 - The purpose of this study was to develop an aggressive locally advanced orthotopic prostate cancer model for assessing high-dose image-guided radiation therapy combined with biological agents. For this study, we used a modified human prostate cancer (PCa) cell line, PC3, in which we knocked down a tumor suppressor protein, DAB2IP (PC3 KD). These prostate cancer cells were implanted into the prostate of nude or Copenhagen rats using either open surgical implantation or a minimally invasive procedure under ultrasound guidance. We report that: i) these DAB2IP-deficient PCa cells form a single focus of locally advanced aggressive tumors in both nude and Copenhagen rats; ii) the resulting tumors are highly aggressive and are poorly controlled after treatment with radiation alone; iii) ultrasound-guided tumor cell implantation can be used successfully for tumor development in the rat prostate; iv) precise measurement of the tumor volume and the treatment planning for radiation therapy can be obtained from ultrasound and MRI, respectively; and v) the use of a fiducial marker for enhanced radiotherapy localization in the rat orthotopic tumor. This model recapitulates radiation-resistant prostate cancers which can be used to demonstrate and quantify therapeutic response to combined modality treatments.

AB - The purpose of this study was to develop an aggressive locally advanced orthotopic prostate cancer model for assessing high-dose image-guided radiation therapy combined with biological agents. For this study, we used a modified human prostate cancer (PCa) cell line, PC3, in which we knocked down a tumor suppressor protein, DAB2IP (PC3 KD). These prostate cancer cells were implanted into the prostate of nude or Copenhagen rats using either open surgical implantation or a minimally invasive procedure under ultrasound guidance. We report that: i) these DAB2IP-deficient PCa cells form a single focus of locally advanced aggressive tumors in both nude and Copenhagen rats; ii) the resulting tumors are highly aggressive and are poorly controlled after treatment with radiation alone; iii) ultrasound-guided tumor cell implantation can be used successfully for tumor development in the rat prostate; iv) precise measurement of the tumor volume and the treatment planning for radiation therapy can be obtained from ultrasound and MRI, respectively; and v) the use of a fiducial marker for enhanced radiotherapy localization in the rat orthotopic tumor. This model recapitulates radiation-resistant prostate cancers which can be used to demonstrate and quantify therapeutic response to combined modality treatments.

KW - Animal MRI

KW - Prostate cancer

KW - Radioresistance

KW - Ultra-sound and image-guided radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84875973015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875973015&partnerID=8YFLogxK

U2 - 10.3892/ijo.2013.1858

DO - 10.3892/ijo.2013.1858

M3 - Article

VL - 42

SP - 1613

EP - 1619

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -